Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christopher Tignanelli and Michael Puskarich.
Christopher Tignanelli
Connection Strength
2.338
Michael Puskarich
  1. A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. EClinicalMedicine. 2021 Jul; 37:100957.
    View in: PubMed
    Score: 0.951
  2. Antihypertensive drugs and risk of COVID-19? Lancet Respir Med. 2020 05; 8(5):e30-e31.
    View in: PubMed
    Score: 0.874
  3. mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses. J Med Virol. 2021 04; 93(4):1843-1846.
    View in: PubMed
    Score: 0.230
  4. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J. 2020 07; 56(1).
    View in: PubMed
    Score: 0.223
  5. A fast, resource efficient, and reliable rule-based system for COVID-19 symptom identification. JAMIA Open. 2021 Jul; 4(3):ooab070.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.